Reversal of Mitochondrial Benefits, Depolarization of Mitochondria in Large Extracellular Vesicle, and Multi-Omics Remodeling After EGCG Plus Omega-3 Withdrawal in Children with Down Syndrome

Down syndrome (DS) is characterized by chronic oxidative stress, mitochondrial dysfunction and metabolic alterations contributing to neurodevelopmental impairment and accelerated aging. We previously showed that supplementation with epigallocatechin-3-gallate (EGCG) plus omega-3 fatty acids improved mitochondrial respiratory chain function in children with DS. Here, we investigated the bioenergetic and molecular consequences of a three-month withdrawal period following chronic supplementation of EGCG plus omega-3 in children with DS aged 6–17 years. Mitochondrial respiratory chain activities in peripheral blood mononuclear cells (n = 8) and mitochondrial content and polarization in large circulating extracellular vesicles (lEVs) (n = 4) were assessed at different time points. Whole-blood RNA sequencing and untargeted plasma metabolomics were performed at the end of supplementation (T0, n = 3) and after three months of withdrawal (T3, n = 4). Treatment discontinuation resulted in progressive loss of the previously observed bioenergetic benefits and the proportion of depolarized mitochondria in circulating lEVs increased at T3. Transcriptomic analysis revealed downregulation of pathways related to oxidative phosphorylation, mitophagy, autophagy, and lysosomal function. Metabolomic profiling showed remodeling of lipid and fatty-acid metabolism, consistent with impaired mitochondrial and redox homeostasis. These findings suggest that the mitochondrial benefits associated with nutraceutical supplementation are not sustained after treatment withdrawal and identify changes in circulating lEV-associated mitochondrial polarization as a potentially informative readout of mitochondrial homeostasis in DS.

Authors

Institutions

Publication Details

Journal
Antioxidants
Published
2026-11-13
DOI
https://doi.org/10.3390/antiox15111471
Primary Topic
Mitochondrial Function and Pathology
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Reversal of Mitochondrial Benefits, Depolarization of Mitochondria in Large Extracellular Vesicle, and Multi-Omics Remodeling After EGCG Plus Omega-3 Withdrawal in Children with Down Syndrome

Daniela Valenti, Apollonia Tullo, Vincenzo Lionetti, Daniela Isabel Abbrescia et al.
1 links
Antioxidants
Mitochondrial Function and Pathology
article

Reversal of Mitochondrial Benefits, Depolarization of Mitochondria in Large Extracellular Vesicle, and Multi-Omics Remodeling After EGCG Plus Omega-3 Withdrawal in Children with Down Syndrome

Daniela Valenti, Apollonia Tullo, Vincenzo Lionetti, Daniela Isabel Abbrescia, Clara Musicco, Rosa Anna Vacca, Sergio Giannattasio, Fabrizio Mastrorocco, Pietro Strisciuglio, Ylenia Antonacci, Iris Scala, Bachir Balech, Flaviana Marzano, Francesca Scebba, Luca De Martino, Claudia Telegrafo, Sara Buccino
article en

Abstract

Down syndrome (DS) is characterized by chronic oxidative stress, mitochondrial dysfunction and metabolic alterations contributing to neurodevelopmental impairment and accelerated aging. We previously showed that supplementation with epigallocatechin-3-gallate (EGCG) plus omega-3 fatty acids improved mitochondrial respiratory chain function in children with DS. Here, we investigated the bioenergetic and molecular consequences of a three-month withdrawal period following chronic supplementation of EGCG plus omega-3 in children with DS aged 6–17 years. Mitochondrial respiratory chain activities in peripheral blood mononuclear cells (n = 8) and mitochondrial content and polarization in large circulating extracellular vesicles (lEVs) (n = 4) were assessed at different time points. Whole-blood RNA sequencing and untargeted plasma metabolomics were performed at the end of supplementation (T0, n = 3) and after three months of withdrawal (T3, n = 4). Treatment discontinuation resulted in progressive loss of the previously observed bioenergetic benefits and the proportion of depolarized mitochondria in circulating lEVs increased at T3. Transcriptomic analysis revealed downregulation of pathways related to oxidative phosphorylation, mitophagy, autophagy, and lysosomal function. Metabolomic profiling showed remodeling of lipid and fatty-acid metabolism, consistent with impaired mitochondrial and redox homeostasis. These findings suggest that the mitochondrial benefits associated with nutraceutical supplementation are not sustained after treatment withdrawal and identify changes in circulating lEV-associated mitochondrial polarization as a potentially informative readout of mitochondrial homeostasis in DS.

AntioxidantsVol. 15(11)
Scuola Superiore Sant'Anna (IT), Federico II University Hospital (IT), Institute of Biomembranes, Bioenergetics and Molecular Biotechnologies (IT), National Research Council (IT), Fondazione Toscana Gabriele Monasterio (IT), Regione Toscana (IT), University of Bari Aldo Moro (IT), University of Naples Federico II (IT)
Good health and well-being
Mitochondrial Function and Pathology
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon